AASLD guidelines classification scheme: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
AASLD (American Association of Study of Liver Disease) provides recommendations for various liver diseases. It develops clinical practice guidelines which are supported by a high level of scientific evidence. They assist in appropriate health care to patients. The clinical practice guidelines should not be looked as "standards of care". They are provided to aid in diagnosis and management of liver diseases. | AASLD (American Association of Study of Liver Disease) provides recommendations for various liver diseases. It develops clinical practice guidelines which are supported by a high level of scientific evidence. They assist in appropriate health care to patients. The clinical practice guidelines should not be looked as "standards of care". They are provided to aid in diagnosis and management of liver diseases.<ref name="urlAmerican Association for the Study of Liver Diseases: Welcome to AASLD">{{cite web |url=http://www.aasld.org/Pages/Default2.aspx |title=American Association for the Study of Liver Diseases: Welcome to AASLD |format= |work= |accessdate=2012-10-25}}</ref> | ||
==Classification of Recommendations== | |||
==References== | ==References== | ||
Revision as of 05:45, 26 October 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
AASLD (American Association of Study of Liver Disease) provides recommendations for various liver diseases. It develops clinical practice guidelines which are supported by a high level of scientific evidence. They assist in appropriate health care to patients. The clinical practice guidelines should not be looked as "standards of care". They are provided to aid in diagnosis and management of liver diseases.[1]
Classification of Recommendations
References
- ↑ "American Association for the Study of Liver Diseases: Welcome to AASLD". Retrieved 2012-10-25.